CURRENT CLINICAL TRIALS

Clinical trials open and close on a regular basis, so check back often to stay up-to-date. If you’re interested in learning more about a particular study you can reach one of our research coordinators by calling 501.620.4449.

TRIALS AVAILABLE IN OUR HOT SPRINGS LOCATION:

ATOPIC DERMATITIS

A Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Study to Evaluate the Efficacy and Safety of XXXXX Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects

PLAQUE PSORIASIS

M16-005: A Multicenter, Single-Arm, Open Label, Assessor-Blinded Study to Assess the Usability of the XXXXX in Adult Patients with Moderate to Severe Plaque Psoriasis

MOLLUSCUM CONTAGIOSUM

A Phase 3 Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study Comparing the Efficacy and Safety of XXXXX and Vehicle Gel Once Daily in the Treatment of Molluscum Contagiosum

ACNE

A Phase 3, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, 2 Arm Parallel Group Study Comparing the Safety and Efficacy of XXXXX Gel and XXXXX Gel in the Treatment of Acne Vulgaris

HIDRADENITIS SUPPURATIVA

A Phase 2, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of XXXXX in Adult Subjects with Moderate to Severe Hidradenitis Suppurativa

 

CHRONIC PRURITIS

A Phase 2 Randomized, Double-Blind, Placebo-Controlled Pilot Study to Investigate the Efficacy, Safety, and Tolerability of XXXXX in Reducing Pruritus in Diseases Characterized by Chronic Pruritus

PLAQUE PSORIASIS

A Multi-Center, Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Phase 3 Study with Randomized Withdrawal and Retreatment to Evaluate the Efficacy and Safety of XXXXX in Subjects with Moderate-to-Severe Plaque Psoriasis

ROSACEA

A randomized, double-blind, parallel-group, three-arm, placebo-controlled, multi-site therapeutic equivalence study with clinical end points comparing test product XXXXX, 1% to Reference Product XXXXX, 1% in the treatment of moderate to severe persistent facial erythema of rosacea

PLAQUE PSORIASIS

A PHASE 2B, RANDOMIZED, DOUBLE BLIND, VEHICLE-CONTROLLED,PARALLEL-GROUP, DOSE RANGING STUDY TO ASSESS EFFICACY, SAFETY,TOLERABILITY AND PHARMACOKINETICS OF XXXXX TOPICAL CREAM APPLIED ONCE OR TWICE DAILY FOR 12 WEEKS IN PARTICIPANTS WITH MILD TO MODERATE CHRONIC PLAQUE PSORIASIS.

TRIALS AVAILABLE IN OUR BRYANT LOCATION:

PRURITIS / ATOPIC DERMATITIS

A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of oral XXXXX for moderate to severe pruritus in adult subjects with atopic dermatitis

PLAQUE PSORIASIS

A Phase 3 Efficacy and Safety Study of XXXXX for the Treatment of Plaque Psoriasis in Adults

MOLLUSCUM CONTAGIOSUM

A Phase 3 Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study Comparing the Efficacy and Safety of XXXXX and Vehicle Gel Once Daily in the Treatment of Molluscum Contagiosum

ATOPIC DERMATITIS

PHASE 3B/4, MULTICENTER, RANDOMIZED, ASSESSOR BLINDED, VEHICLE AND ACTIVE XXXXX CONTROLLED, PARALLEL GROUP STUDY OF THE EFFICACY, SAFETY, AND LOCAL TOLERABILITY OF XXXXX, 2% IN PEDIATRIC AND ADULT SUBJECTS (AGES 2 YEARS AND OLDER) WITH MILD TO MODERATE ATOPIC DERMATITIS

ATOPIC DERMATITIS

A MULTICENTER, RANDOMIZED, PHASE 2, DOUBLE-BLIND, VEHICLECONTROLLED,PARALLEL GROUP COMPARISON STUDY TO EVALUATE THE SAFETY AND EFFICACY OF XXXXX CREAM IN ADOLESCENTS AND ADULTS WITH MILD TO MODERATE ATOPIC DERMATITIS

Contact
501.620.4449

3633 Central Avenue, Suite I, Hot Springs, AR 71913